Does GLP-1 Help With PCOS? What UK Adults Should Know (October 2026)

01 · The core answer

Can GLP-1 medicines help PCOS? The short answer

Yes, they can help, but mostly by way of weight loss rather than by treating PCOS directly. Mounjaro is not licensed specifically for PCOS, but many women with PCOS meet the licensed weight-management criteria, and weight loss itself is a first-line recommendation that can improve insulin resistance, cycles and symptoms.¹ It means the medicine is prescribed for the weight-management indication, and any change in PCOS symptoms is a welcome knock-on effect rather than a licensed promise.

PCOS looks different from one woman to the next. Some have irregular cycles and little else. Others have insulin resistance, difficulty losing weight, skin and hair changes, or fertility concerns. A medicine that helps with weight and with how the body responds to insulin can touch several of those areas, but nobody can tell you in advance which ones will improve for you. Our related guide on Mounjaro and PCOS looks at the tirzepatide side in more detail, and a shorter explainer on GLP-1 medicines and PCOS covers the basics.

02 · What you are deciding

The decisions you are actually facing

Most women asking this question are deciding between two things: whether a GLP-1 medicine is relevant to them at all, and what to do next if it is. Relevance comes down to the licensed criteria. Eligibility is assessed on the standard BMI criteria, not on a PCOS diagnosis. If your BMI and health picture fit the licensed weight-management use, the medicine may be an option. If they do not, PCOS alone does not change that.

The second decision is how to access treatment. NHS access is being phased in over several years, so many people look at regulated private treatment. Either way, a prescriber needs the full picture. Tell them you have PCOS, tell them about any plans to conceive, and tell them which contraception you use.

03 · Your pathway

What to do next if this sounds relevant

If you meet the licensed criteria and want to explore treatment, the simplest route is a free online consultation that is reviewed by a GPhC-registered prescriber. You can see how the process works on the Mounjaro pen page, and our weight loss clinic page explains the wider service. Our guide to weight loss with PCOS is a good companion read if weight is your main concern.

Before you apply, it helps to have a few things ready: your approximate height and weight, a list of any medicines you take, details of your contraception, and a clear idea of whether you hope to conceive. Having those to hand makes the consultation quicker and the prescriber's decision better informed. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full.

04 · How GLP-1 medicines work

How GLP-1 medicines work

GLP-1 medicines work by acting on natural gut-hormone pathways that regulate appetite, and that is the starting point for understanding any PCOS benefit. Mounjaro is the brand name for tirzepatide, a once-weekly injectable prescription medicine made by Eli Lilly. In the UK it is licensed for weight management in adults and for type 2 diabetes. It comes as a pre-filled multi-dose pen (KwikPen) in six strengths: 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg.¹

Tirzepatide is the first treatment of its kind to activate two natural gut-hormone receptors at once: GIP and GLP-1. Together these help regulate appetite, slow how quickly the stomach empties, and improve the way the body responds to insulin.¹ In practice, most people feel fuller sooner and less hungry between meals, which supports a reduced-calorie diet. This dual action is what distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).

Why does this matter for PCOS? Because these three effects line up with problems that many women with PCOS describe. Appetite that is hard to settle, difficulty losing weight even with effort, and a body that does not respond well to insulin are all common themes. A medicine that quiets appetite and improves insulin response is therefore a sensible fit for the weight-management side of PCOS. The licensed use remains weight management and type 2 diabetes.

It also helps to be clear about what the medicine is not. It is not a hormone treatment. It is used alongside a reduced-calorie diet and increased physical activity, not instead of them.

The practical upshot is simple: the medicine helps you eat less without constant struggle, and the weight you lose is what may then ease PCOS symptoms.

One further point about timing: tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.

Finally, remember that the term GLP-1 is used loosely online. Some medicines act on GLP-1 alone, and tirzepatide acts on GLP-1 and GIP. When you read PCOS discussions that treat all of them as identical, treat that with caution. Your prescriber can explain how the medicine they recommend differs from the others.

05 · The PCOS and weight link

The link between PCOS, weight and insulin

The clearest link between GLP-1 medicines and PCOS runs through weight and insulin. Mounjaro is not licensed specifically for PCOS, but many women with PCOS meet the licensed weight-management criteria, and weight loss itself is a first-line recommendation that can improve insulin resistance, cycles and symptoms.¹

It is worth unpacking what each of those words means in plain terms. Insulin resistance describes a body that needs more insulin to do the same job. Cycles refers to the pattern of your periods and ovulation. Symptoms covers the wider picture a woman may experience. For women who carry extra weight, losing some of it can ease these areas. Not every woman will see every improvement.

Some women may notice changes in their cycles as weight comes down and others may notice little, so it helps to be reviewed over time by a clinician who knows your history.

It also helps to separate causes from effects. PCOS can make weight harder to lose, and extra weight can make PCOS symptoms more pronounced. That circular relationship is why a medicine that supports weight loss attracts interest. But if your PCOS is mostly about irregular cycles and you are at a healthy weight, a GLP-1 medicine is not designed for you and would not be appropriate.

Our related guides explore this from different angles. If you want to see how people use tirzepatide specifically, read PCOS symptoms on Mounjaro. For a broader overview of both topics together, see our GLP-1 and PCOS overview.

One practical suggestion is to keep a simple record before you start: cycle dates, any symptoms that bother you, and your weight. A record lets you and your prescriber see over time whether things are shifting, rather than relying on memory. Review appointments are the place to discuss what you are noticing, and the aftercare from our prescribing team includes ongoing monthly reviews and follow-up assessments.

Eligibility is assessed on the standard BMI criteria, and NICE guidance sets how the medicine is used in the NHS.⁴ PCOS is something to mention, because it informs the conversation, but it is not a separate pathway into treatment.

06 · What the trial evidence shows

What the trial evidence does and does not show

The best-known trial of Mounjaro for weight loss did not study women with PCOS specifically, so its results are context rather than a PCOS forecast. In the SURMOUNT-1 trial of 2,539 adults, people taking tirzepatide alongside diet and exercise lost on average 15% of their body weight on 5mg, 19.5% on 10mg and 20.9% on 15mg over 72 weeks, compared with 3.1% with lifestyle changes alone.²

These are trial averages — individual results vary, and treatment works alongside a reduced-calorie diet and increased physical activity, not instead of them. At 72 weeks, 85% of participants on 5mg, 89% on 10mg and 91% on 15mg had lost at least 5% of their body weight. Half of participants on 10mg and 57% on 15mg lost at least 20% of their body weight.²

What can you reasonably take from that? First, that the medicine produced substantial average weight loss in adults with obesity under trial conditions. Second, that the result depended on the dose and on continued lifestyle changes. A worked example makes it concrete: for someone starting at 100 kg, 20.9% is about 21 kg. That is arithmetic on a trial average, not a prediction for any individual.

What you cannot take from it is a PCOS result. The trial figures do not tell you how many women with PCOS will see their periods return, how insulin resistance will change, or whether fertility will improve.

It is also worth noting that trial averages do not predict your own result. Some people lose more than the average, some lose less, and the dose you reach and the support you have around you all play a part. Weight loss with PCOS may be slower or faster than for someone without it, and nobody should promise otherwise.

Our page on weight loss with PCOS takes the trial context into a PCOS setting without overstating it.

07 · Eligibility and NHS access

Does PCOS qualify you? Eligibility, NHS and private routes

PCOS does not qualify you for treatment on its own; eligibility is assessed on the standard BMI criteria. The licensed use is weight management in adults and type 2 diabetes, so a prescriber looks at your BMI, any weight-related conditions and your overall health.¹

On the NHS side, the picture is phased. Mounjaro is available on the NHS, but access is being phased in over several years. NICE recommends it for adults with a BMI of at least 35 plus at least one weight-related condition, and the NHS primary-care rollout began in June 2025 with the highest-need groups first (initially BMI 40+ with four or more qualifying conditions).⁴⁶ Full rollout is expected to take years, which is why many people who meet the licensed criteria choose regulated private treatment rather than waiting.

If you are weighing up the NHS route, start with your GP. Ask whether you fall within the current priority groups in your area, and mention your PCOS because it is part of your medical history. You can read the NHS overview of the medicine in its own guide.⁵ Your GP may also discuss other PCOS care options with you.

The private route works differently. You complete a free online consultation, and a GPhC-registered prescriber reviews your answers. It is a real clinical review rather than a scoring script, and if treatment is unsuitable your order is refunded automatically. Our pharmacy is registered with the GPhC under number 9012878, and you can check the register yourself.¹²

It is reasonable to ask why you would choose one route over the other. The NHS route costs nothing beyond the usual prescription charge in England, which is £9.90 where one applies, but access depends on local rollout and priority groups. The private route is available to adults who meet the licensed criteria, and you pay for the medicine. Neither route is better for everyone; it comes down to whether you qualify for NHS treatment now and how long you are willing to wait.

Whichever you choose, be honest about your weight, your history and your goals. A prescriber can only make a safe decision with accurate information. If you are close to a BMI threshold, say so, and expect to be asked about other conditions that may count. If you are not eligible, that is a clinical decision made for your protection, not a reflection of how much you want help.

Finally, remember that a medicine is one part of PCOS care. Diet, activity, sleep and any treatments your GP recommends continue to matter, and a good prescriber will treat them as part of the same plan.

08 · Fertility and contraception

Fertility, contraception and pregnancy planning

If you have PCOS and are thinking about pregnancy, tell your prescriber at the start, because improving weight can restore ovulation. Eligibility is assessed on the standard BMI criteria, and you should mention PCOS and any fertility plans in your consultation, because improving weight can restore ovulation.¹

The reason this matters is practical. If ovulation returns as weight comes down, pregnancy becomes more possible, including for women who were told it would be difficult. That can be welcome news if you are hoping to conceive, and a real surprise if you are not. It means that anyone who is sexually active and does not want to become pregnant should discuss reliable contraception with their prescriber before starting.

On contraception specifically, Mounjaro slows stomach emptying, which can reduce how well oral contraceptive pills are absorbed. The SmPC advises switching to a non-oral method, or adding a barrier method (such as condoms), for 4 weeks after starting Mounjaro and for 4 weeks after each dose increase.¹ That is why it is important to tell the prescriber which method you use, so they can advise you on whether it needs adding to or changing.⁷

If you are planning a pregnancy, discuss timing with your prescriber well before you stop using contraception. Mounjaro must not be used during pregnancy, and it should be stopped at least one month before trying to conceive. If you become pregnant during treatment, stop the medicine and tell your prescriber promptly. Tirzepatide has a half-life of about five days, so after a final dose it takes roughly four to five weeks to clear the system. There is no way to speed this up, and nothing needs doing while it clears.¹

It is also sensible to be open about any other PCOS treatments you take, such as medicines prescribed by your GP or specialist. Your prescriber needs the full list of medicines to check for interactions and to make sure treatments do not conflict. If you use insulin or sulfonylureas for diabetes, doses may need adjusting because of the risk of low blood sugar, and your prescriber will advise.

Finally, if you notice new or unexpected symptoms after starting, speak to your prescriber. You can also report suspected side effects through the MHRA Yellow Card scheme.¹⁹ Serious side effects are uncommon but need urgent attention. Seek immediate medical help for severe, persistent stomach pain that may spread to your back, with or without vomiting (possible pancreatitis); pain in the upper right abdomen, fever or yellowing of skin or eyes (possible gallbladder problems); or signs of a severe allergic reaction such as swelling of the face or throat and difficulty breathing. Reporting helps regulators monitor safety, and it is something any patient or carer can do.

In short, the combination of PCOS, possible return of ovulation and a medicine that affects contraception absorption is exactly why honesty at the consultation matters. Share your plans, whatever they are, and let the prescriber help you stay safe.

09 · Choosing between options

Which medicine suits PCOS? Comparing the options

None of them is licensed specifically for PCOS. That means anyone who tells you one product is the PCOS medicine is going beyond what the product information supports.

Tirzepatide activates two natural gut-hormone receptors at once, GIP and GLP-1, which distinguishes Mounjaro from single-action GLP-1 medicines such as semaglutide (Wegovy/Ozempic).¹ Mounjaro comes in six strengths, from 2.5mg to 15mg. Liraglutide, supplied at 6mg/ml, is a daily injection, unlike once-weekly Mounjaro and Wegovy.

The question of Mounjaro against Ozempic comes up often. Ozempic is semaglutide licensed for type 2 diabetes only; it is not a UK weight-loss medicine, and a regulated UK pharmacy will not supply it for weight loss. The licensed weight-management semaglutide option is Wegovy. A prescriber can explain which is appropriate for your situation. You can look at the Wegovy pen alongside the Mounjaro pen if you are comparing.

What about metformin? Metformin is a different type of medicine that your GP may already have discussed with you for PCOS. The sensible answer is that they are not interchangeable, they work differently, and whether you use one, the other or both is a decision for you and your clinician.

How should you decide, then? Start with the licensed question: do you meet the weight-management criteria? If so, think about practicalities such as injection frequency, how you feel about stepping up doses gradually, and whether a once-weekly pen suits your routine. Then think about your wider PCOS care and what your GP or specialist has already recommended.

Two GLP-1 weight-loss tablets, Wegovy tablets and Foundayo, are now licensed in the UK; no trial has compared Mounjaro directly with either, so check current details on the relevant product pages.

The bottom line is that the right option is the one that is licensed for your situation, that your prescriber judges to be safe, and that you can realistically stick with. That is a clinical judgement made with you, not a fixed league table.

10 · Costs, ordering and aftercare

Costs, ordering and ongoing support

If you decide to go ahead privately, here is how cost works. The Mounjaro starting pen at 2.5mg has a standard price of £169.99 per month, and a new customer's first 2.5mg pen costs £129.99 with code FIRST40. After that, every later order is £25 off the standard price (code DOSE25). The first-order discount applies at any dose, including for people switching to us from another provider. Prices were checked 10 October 2026.

Looking ahead, if you step up after 4 weeks on each dose, your first four pens (2.5mg to 10mg) cost £959.96 at standard prices. A first year costs £2,711.88 if you stay on 5mg after your 2.5mg starting pen, up to £3,599.88 if you step up through every dose to 15mg. These figures are before discounts: a new customer's first order is £40 less and every later order £25 less. Other maintenance doses are priced per month, for example 7.5mg at £279.99, 10mg at £290.99 and 12.5mg at £319.99. You can see the full live prices on the Mounjaro pen page, and all six doses are in stock.

Ordering follows a simple sequence. You begin with a free online consultation, a short health questionnaire with no charge and no obligation. Payment is taken when you place the order; if the prescriber decides the treatment is not suitable, the order is refunded automatically in full. Once approved, the medicine is dispensed by our registered pharmacy, with same-day dispatch when ordered by 3pm, and delivered free next day by tracked, temperature-controlled courier in discreet packaging. Saturday delivery is £14.99.

The medicine itself is genuine: we supply Mounjaro through official LillyDirect supply, direct from Eli Lilly's UK distribution, in genuine KwikPens. That matters because counterfeit medicines are a real risk when people buy from sellers who offer to supply without a consultation or prescription. The MHRA publishes counterfeit alerts, and you should only buy from a registered pharmacy that checks your suitability.⁷

Ongoing care is part of the service. Monthly reviews, dose-titration and follow-up assessments are carried out by the prescribing team, and there is side-effect support. Repeat orders re-check suitability, and nothing is shipped automatically, so you stay in control. Needles, a sharps bin and injection guidance come with every order. Support is available Monday to Friday, 9am to 5pm, by email at support@everydaymeds.co.uk, through the account portal chat or by phone on 0333 207 0413.

For storage, keep unopened pens in the fridge at 2–8°C until first use, and they keep until the printed expiry date. Once in use, a KwikPen can be kept out of the fridge for up to 30 days (not above 30°C).¹³ Payment is by Visa or Mastercard, Klarna or pay-monthly options, and there is no subscription. The free GLPTrackr app can help you track your journey, including notes that may be useful at review appointments.

This medicine is prescription-only, supplied only after an online consultation reviewed by a GPhC-registered prescriber. It is used alongside a reduced-calorie diet and increased physical activity. Individual results vary. This page is information, not a substitute for medical advice.